DBV Technologies | DBVT - 借入資本





借入資本 変化する 日付
Acadia Pharmaceuticals USD 0 0 2025-03
Alnylam Pharmaceuticals USD 2.48B 1.44B 2025-12
BioCryst Pharmaceuticals USD 428.67M 234.31M 2025-12
BioMarin Pharmaceutical USD 597.18M 513K 2025-12
DBV Technologies USD 0 0 2025-03
Esperion Therapeutics USD 457.65M 9.5M 2025-12
Galectin Therapeutics USD 93.42M 9.08M 2024-06
Halozyme Therapeutics USD 2.14B 1.34B 2025-12
Incyte USD 30.2M 5.17M 2025-12
Insmed USD 540.96M 1.24M 2025-12
Ionis Pharmaceuticals USD 1.9B 1.87B 2025-12
Neurocrine Biosciences USD 169.5M 500K 2023-03
PTC Therapeutics USD 2.03B 193.22M 2025-12
Sarepta Therapeutics USD 828.97M 206.17M 2025-12
Ultragenyx Pharmaceutical USD 763.74M 19.02M 2025-09
United Therapeutics USD 100M 100M 2024-06